Funder
Janssen Pharmaceuticals KK
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference55 articles.
1. Nakane Y, Ohta Y, Radford MH. Epidemiological studies of schizophrenia in Japan. Schizophr Bull. 1992;18(1):75–84.
2. McGrawth JJ. Variations in the incidence of schizophrenia: data versus dogma. Schizophr Bull. 2006;32(1):195–7. doi: 10.1093/schbul/sbi052 .
3. Sado M, Inagaki A, Koreki A, Knapp M, Kissane LA, Mimura M, Yoshimura K. The cost of schizophrenia in Japan. Neuropsychiatr Dis Treat. 2013;9:787–98.
4. Lin I, Muser E, Munsell M, Benson C, Menzin J. Economic impact of psychiatric relapse and recidivism among adults with schizophrenia recently released from incarceration: a Markov model analysis. J Med Econ. 2014;26:1–11.
5. Fitch K, Iwasaki K, Villa K. Resource utilization and cost in a commercially insured population with schizophrenia. Am Health Drug Benefits. 2014;7(1):18–26.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献